PEDS1-UBE2V1

Across TCGA pan-cancer cohorts, PEDS1-UBE2V1 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of PEDS1-UBE2V1’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where PEDS1-UBE2V1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types PEDS1-UBE2V1 is over-expressed in tumor.

HNSC, LUSC, and STAD are the cancer types where PEDS1-UBE2V1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in PEDS1-UBE2V1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	Male	All	+0.074	<.001	8	view →
LUSC	All	All	+0.055	<.001	7	view →
STAD	Male	IV	+0.045	.012	3	view →
KIRP	Female	II,III,IV	+0.044	.003	3	view →
LIHC	Female	All	+0.013	.020	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

PEDS1-UBE2V1–HNSC

Open the HNSC breakdown →